Hudson Regional Hospital’s Cardiac Catheterization Lab has earned NJ State Department of Health approval for STEMI ...

Glucagon-like peptide-1 receptor agonist use corresponded with risk reductions for dozens of diseases and adverse health ...

Aim In the clinical setting of acute myocarditis, existing guidelines recommend refraining from moderate-intensity to ...

New study finds further evidence that existing measures, such as body mass index (BMI) or waist circumference, are not ...

Regardless of age at diagnosis or duration of disease, patients with diabetes who underwent intensive glucose lowering had lower risk for vascular events and death, according to a post hoc analysis ...

Bradycardia is a condition characterized by a slower than normal heart rate. While a normal adult heart beats between 60 and ...

A new study reveals that popular diabetes and weight loss medications like Ozempic and Wegovy may offer unexpected health ...

A study published by researchers from the Sant Pau Research Institute (IR Sant Pau) and the Stroke Unit of Sant Pau Hospital ...

President Donald Trump’s second inauguration seemed normal, but there were concerns about U.S. democracy lingering just ...

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2024. The list includes several groundbreaking therapies that are expected to change the ...

The incorporation of Lisinopril 20 milligrams to the basic list of medicines for patients with arterial hypertension prompted ...

Primary and secondary outcome measures As specified in the analysis plan, the primary outcome measures were first occurrence of admission or death due to myocardial infarction and time to event. There ...